STARTUP PROFILE

Syntropic

COUNTRY
Austria
FOUNDED
2023
CATEGORY
Neuromodulation
Using 60 Hz non-invasive light stimulation via the eyes to trigger microglia-mediated neuroplasticity, offering a fast, drug-free option for depression and brain recovery.
Visit website →
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Light/sound
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Syntropic is pursuing light-based brain stimulation for depression and recovery, with a mechanistic narrative centered on neuroplasticity and microglial response. This is unusual and scientifically interesting, but still firmly preclinical.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Syntropic
No items found.